Search International and National Patent Collections

1. (WO2018026249) ANTIBODY AGAINST PROGRAMMED DEATH-LIGAND 1 (PD-L1), AND USE THEREOF

Pub. No.:    WO/2018/026249    International Application No.:    PCT/KR2017/008495
Publication Date: Fri Feb 09 00:59:59 CET 2018 International Filing Date: Tue Aug 08 01:59:59 CEST 2017
IPC: C07K 16/28
A61K 39/395
A61K 39/00
Applicants: Y-BIOLOGICS INC.
주식회사 와이바이오로직스
Inventors: PARK, Jae Eun
박재은
CHOI, Soo A
최수아
LEE, Jisu
이지수
LEE, Hyun Mi
이현미
LEE, Si Hyung
이시형
BAEK, Gi Sun
백기선
KIM, Yeung Chul
김응철
PARK, Bum-chan
박범찬
LIM, Jung Chae
임정채
CHO, Young-Gyu
조영규
PARK, Young Woo
박영우
Title: ANTIBODY AGAINST PROGRAMMED DEATH-LIGAND 1 (PD-L1), AND USE THEREOF
Abstract:
The present invention relates to an antibody against programmed death-ligand 1 (PD-L1) or an antigen-binding fragment thereof, a nucleic acid for coding same, a vector comprising the nucleic acid, a cell transformed with the vector, a method for preparing the antibody or the antigen-binding fragment thereof, and a composition, comprising same, for preventing or treating a cancer or an infectious disease.